https://www.selleckchem.com/products/gdc-0068.html
TGI-OS models adequately described the OS distribution. The model-predicted HRs indicated good model performance across the 10 studies, with observed HRs within the 95% prediction intervals for all study arms versus controls. Multivariate TGI-OS models developed for different solid tumor types were able to predict treatment effect with various atezolizumab monotherapy or combination regimens and could be used to support design and analysis of future studies. The diagnosis of myelodysplastic syndromes (MDS) and myelodysplastic/myeloprol
Curtir
Comentario
Compartilhar
